Abstract
WS06-4 Ivacaftor (IVA) treatment in patients 6 to <12 months old with cystic fibrosis with a CFTR gating mutation: results of a 2-part, single-arm, phase 3 study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have